… 9:25 a.m. Lupin, Biocon, Aurobindo Pharma, and Laurus Labs … ’s 200% Tariff Threat; Lupin, Biocon Top Gainers Disclaimer: Comments reflect …

… stocks, including Laurus Labs, Lupin, Biocon, Cipla and Divi's …

Biocon Limited has informed stock exchanges … for Prevention of Insider Trading, Biocon has closed its trading window … within 5 working days on Biocon’s investor relations website The …

… Wegovy and Mounjaro already here, Biocon is quietly planning a global …

… The denosumab biosimilars mark Biocon’s third and fourth … UK biosimilars market For Biocon Biologics, the marketing … 5). References 1. Biocon Biologics. Biocon Biologics Receives MHRA UK … 7, 2025. 5. Biocon Biologics. Biocon Biologics Receives MHRA Approval …

… biosimilars company and subsidiary of Biocon, has announced that the Medicines … ) recently granted marketing authorisation for Biocon Biologics Denosumab biosimilars, allowing their …

… 02:57 PM New Delhi: Biocon Ltd on Monday said its … arm Biocon Biologics Ltd has received … advanced malignancies involving bone, Biocon said in a regulatory filing … increased risk of fractures. Biocon Biologics was recently granted marketing …

… Monday said its arm Biocon Biologics Ltd has received marketing … with advanced malignancies involving bone, Biocon said in a regulatory filing … at increased risk of fractures. Biocon Biologics was recently granted marketing …

… company and subsidiary of Biocon Ltd., today announced that … recently granted marketing authorisation for Biocon Biologics Denosumab biosimilars, allowing … Source : Equity Bulls Keywords Biocon INE376G01013 Biotechnology BioconBiologics UKMHRA Approval …

… biosimilars company and subsidiary of Biocon Ltd., has received marketing authorisations … ) recently granted marketing authorisation for Biocon Biologics Denosumab biosimilars, allowing their … giant cell tumour of bone Biocon Limited, publicly listed in 2004 …